GlassScriptPhysician profile
Joshua Adam Tepper
NPI 1114183514
$21,960.33
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $97.25 · 2021: $5,321 · 2022: $136 · 2023: $2,999.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,888 · Food and Beverage: $112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,887.50 |
| Food and Beverage | $111.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $20,401.85 | 2019-2023 | Autoplex, Avaflex, Ivas |
| Vertiflex, INC. | $802.22 | 2019 | |
| Angiodynamics, INC. | $369.23 | 2019-2020 | |
| Boston Scientific Corporation | $213.73 | 2020-2022 | |
| Sun Pharmaceutical Industries INC. | $33.62 | 2019-2022 | |
| Intuitive Surgical, INC. | $29.13 | 2023 | Da Vinci Surgical System |
| Cook Medical LLC | $24.03 | 2019-2020 | |
| Medtronic, INC. | $16.47 | 2023 | Abre |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $16.35 | 2022 | |
| Terumo Medical Corporation | $14.94 | 2023 | Azur Cx Detachable, Navicross, Glidewire |
| Almirall LLC | $14.38 | 2020 | |
| Abbvie INC. | $13.17 | 2019 | |
| Medtronic USA, INC. | $11.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Tepper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.